Publication | Closed Access

A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma

Sequential PaclitaxelGastrointestinal OncologyMedicinePathologyAdvanced GastricNsc 339555Cancer TreatmentOncologyRadiation OncologyCancer Research